Hubungan Usia dengan Kualitas Hidup pada Pasien Karsinoma Ovarium Stadium Lanjut yang Menerima Kemoterapi Carboplatin-Paclitaxel Menggunakan Skoring EORTC QLQ-C30 di RSUD Dr. Moewardi

M, RABBANI ICKSAN (2017) Hubungan Usia dengan Kualitas Hidup pada Pasien Karsinoma Ovarium Stadium Lanjut yang Menerima Kemoterapi Carboplatin-Paclitaxel Menggunakan Skoring EORTC QLQ-C30 di RSUD Dr. Moewardi. Other thesis, Universitas Sebelas Maret.

[img] PDF - Published Version
Download (291Kb)

    Abstract

    Rabbani Icksan Maulana, G0013192, 2016. Association Between Age and Quality of Life on Advanced Stage Ovarian Cancer Patients Receiving Carboplatin-Paclitaxel Chemotherapy Using EORTC QLQ-C30 Scoring in RSUD Dr. Moewardi. Mini Thesis, Faculty of Medicine, Sebelas Maret University, Surakarta. Introduction: Ovarian cancer is a gynecologic malignancy with high mortality. Many factors thought contribute to ovarian cancer patients’ quality of life. Age is one of the factors thought to affect quality of life. This study aim is to determine the association between age and quality of life on advanced stage ovarian cancer patients undergoing carboplatin-paclitaxel chemotherapy in RSUD Dr. Moewardi. Methods: This study was analytical observational that conducted in Obstetrics and Gynecology Clinic of RSUD Dr. Moewardi. Samples were 30 advanced stage ovarian cancer patients undergoing carboplatin-paclitaxel chemotherapy. Sample were obtained using consecutive sampling technique. Indonesian version of EORTC QLQ-C30 questionnaire that had been validated were used to measure quality of life. Quality of life measurement were conducted 2 weeks after carboplatin-paclitaxel administration. Age data were divided into two groups (<60 year old and >60 year old) while quality of life data were divided into “well” and “poor” based on EORTC QLQ-C30 reference data published by Fayers et al (2001). The data were then analyzed using chi-square test. Fisher exact test were used as alternative test if the data could not met the criteria for chi-square test. Results: Older patients (>60 year old) tend to score higher global quality of life than younger patients (<60 year old) based on EORTC QLQ-C30 (p = 0,029). Fisher exact test results for age and functional scales and symptom scales showed no significant assocation (p > 0,05). Conclusion: Age was associated with global quality of life in advanced stage ovarian cancer patients underwent carboplatin-paclitaxel chemotherapy using EORTC QLQ-C30 scoring in RSUD Dr. Moewardi. Age had no association with functional and symptom scales. Keywords: Age, Quality Of Life, Ovarian Cancer, Chemoteraphy, EORTC QLQ-C30

    Item Type: Thesis (Other)
    Subjects: R Medicine > R Medicine (General)
    Divisions: Fakultas Kedokteran
    Fakultas Kedokteran > Pendidikan Kedokteran
    Depositing User: Rina Dwi Setianingrum
    Date Deposited: 06 Apr 2017 11:16
    Last Modified: 06 Apr 2017 11:16
    URI: https://eprints.uns.ac.id/id/eprint/33297

    Actions (login required)

    View Item